Infection and Immunity, October 2000, p. 5663-5667, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Vanderbilt University School of Medicine and VA Medical Center, Nashville, Tennessee1; Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, Georgia4; and Department of Farm Animal and Equine Medicine and Surgery, Royal Veterinary College, Potters Bar, Hertfordshire,2 and Veterinary Laboratories Agency (Weybridge), New Haw, Surrey,3 United Kingdom
Received 3 April 2000/Returned for modification 27 May 2000/Accepted 4 July 2000
| |
ABSTRACT |
|---|
|
|
|---|
Phase variation of Campylobacter fetus surface layer proteins (SLPs) occurs by inversion of a 6.2-kb DNA segment containing the unique sap promoter, permitting expression of a single SLP-encoding gene. Previous work has shown that the C. fetus sap inversion system is RecA dependent. When we challenged a pregnant ewe with a recA mutant of wild-type C. fetus (strain 97-211) that expressed the 97-kDa SLP, 15 of the 16 ovine-passaged isolates expressed the 97-kDa protein. However, one strain (97-209) expressed a 127-kDa SLP, suggesting that chromosomal rearrangement may have occurred to enable SLP switching. Lack of RecA function in strains 97-211 and 97-209 was confirmed by their sensitivity to the DNA-damaging agent methyl methanesulfonate. Southern hybridization and PCR of these strains indicated that the aphA insertion into recA was stably present. However, Southern hybridizations demonstrated that in strain 97-209 inversion had occurred in the sap locus. PCR data confirmed inversion of the 6.2-kb DNA element and indicated that in these recA mutants the sap inversion frequency is reduced by 2 to 3 log10 units compared to that in the wild type. Thus, although the major sap inversion pathway in C. fetus is RecA dependent, alternative lower-frequency, RecA-independent inversion mechanisms exist.
| |
INTRODUCTION |
|---|
|
|
|---|
Campylobacter fetus causes infertility and spontaneous abortions in ungulates, as well as intestinal and systemic diseases in both normal and immunocompromised humans (1). C. fetus surface layer proteins (SLPs) form a protective capsule for the organism (41) that is critical for virulence (27). C. fetus cells can express any of eight or nine SLPs that range in mass from 97 to 149 kDa (36). Each SLP is encoded by a promoterless sapA homolog (10), and SLP phase variation occurs by inversion of a 6.2-kb DNA segment, which contains a single outward-facing sapA promoter (8). The sapA (2) and sapA2 (12) homologs, expressing 97- and 127-kDa SLPs, respectively, flank the 6.2-kb invertible region in wild-type strain 23D. The invertible region contains an operon of four genes (sapCDEF), in which SapD, -E, and-F constitute a type I secretion system necessary for the extracellular transport of SLPs, while the function of SapC is unknown (35).
RecA is a highly conserved bacterial protein that facilitates DNA rearrangement via homologous recombination (30). In other bacterial species, including Salmonella species, Bordetella pertussis (24), and Escherichia coli (39), DNA inversion leading to phase variation has been shown to be RecA independent (6, 20, 23, 26, 29, 31). In contrast, in studies using the defined C. fetus mutant strain 23D:AC200 in which a chloramphenicol (cat) resistance cassette without a functional promoter was inserted into sapA, no inversion events could be detected after recA was interrupted (9). Complementation by recA in trans restored inversion, thus suggesting that recA function was required (11), which is consistent with the long (approximately 625-bp) 5' conserved regions of DNA identity in each of the sap homologs.
However, following recent experimental infection of sheep with a C. fetus recA mutant, one strain (97-209) was recovered in which the molecular mass of the expressed SLP had shifted (19). The aim of the present study was to investigate this observed shift in SLP expression. Two mechanisms were considered: reversion of the recA mutation in 97-209 or occurrence of a DNA rearrangement in the absence of RecA function. We demonstrated that the recA mutation had been maintained in strain 97-209 during in vivo passage but that sap rearrangement had occurred. We found that although RecA function is critical for high-frequency inversion, RecA-independent sap inversion can occur at a lower frequency.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and culture conditions.
The C. fetus strains used in this study are listed in Table
1. In prior studies (19), a
pregnant ewe was challenged with recA mutant 97-211, which
expresses a 97-kDa SLP. Although all of the isolates recovered from the
animal were expected to express a 97-kDa SLP, as observed in 97-210, one (97-209) expressed a 127-kDa SLP. All C. fetus cells
were grown on brucella agar containing polymyxin B sulfate (7,000 U/ml), vancomycin (10 µg/ml), nalidixic acid (15 µg/ml),
trimethoprim lactate (10 µg/ml), and, when required, kanamycin (30 µg/ml). Strains were cultured at 37°C under microaerobic conditions. All isolates were kanamycin resistant, reflecting the
presence of aphA in recA, and Southern
hybridization studies indicated that all shared the same genetic
background.
|
Immunoblot assay. Whole-cell preparations of strains 23D, 23B, 97-209, and 97-211 were prepared as described previously (32). Protein concentrations were determined by bicinchoninic acid assay (Pierce, Rockford, Ill.), and 1 µg of protein was assayed by electrophoresis on a sodium dodecyl sulfate-7% polyacrylamide gel. S-layer proteins were detected with polyclonal rabbit serum (1:10,000 dilution) raised against the C. fetus type A 97-kDa SLP, as described previously (28), using goat anti-rabbit immunoglobulin G-alkaline phosphatase (Boehringer Mannheim, Indianapolis, Ind.) (1:2,000 dilution) as the secondary antibody. These antibodies recognize C. fetus SLPs of all molecular masses (28, 38). Strains 97-211s and 97-209s also were assayed by immunoblotting to determine whether any change in SLP phenotype had occurred.
Serum susceptibility assay.
Cells of selected C. fetus strains were harvested from brucella agar plates after
48 h and resuspended in saline (pH 7.0) with 1 mM calcium
chloride, as described previously (5). Bacterial suspensions
were diluted 10-fold from 10
1 to 10
7, and
the 10
4 to 10
7 dilutions were incubated in
the presence of 10% normal human serum (NHS) or heat-inactivated NHS
at 37°C in an atmosphere with 5% CO2 for 60 min.
Triplicate samples were then inoculated on blood agar plates, and
colonies were counted after 72 h as described previously
(10).
Sensitivity to MMS.
Bacterial cells were harvested after
48 h of growth and resuspended in 3 ml of brucella broth. The cell
suspension then was diluted 10-fold, and 1 ml was incubated either in
brucella broth with 0.05% methyl methanesulfonate (MMS) or in broth
alone for 60 min 37°C with gentle shaking. Serial 10
4
to 10
7 dilutions of the cell suspensions were inoculated
in triplicate onto blood agar plates. Cells were sampled both before
and after exposure to MMS. Plates were incubated at 37°C for 72 h under microaerobic conditions, and then colonies were counted to
determine sensitivity to MMS. Colonies of strains 97-211 and 97-209 that survived MMS incubation were recultured and again exposed to MMS, and survival frequencies were determined as described above.
Southern-hybridization.
C. fetus chromosomal DNA
was prepared using the Wizard Genomic DNA Purification Kit (Promega,
Madison, Wis.), digested with either NdeI or
PstI, electrophoresed on a 0.7% agarose gel, and transferred to a nylon membrane (MSI, Westborough,
Mass.)(12,13). The hybridization probes used were PCR
products specific for recA (primers B9088 and B9089) (Table
2), the sapA 5' conserved
region (primers B9343 and AN1199), sapF (primers A7308 and
7315), and the gel-purified aphA fragment from pILL600
Smal digestion (25). Probes were labeled using
the Renaissance chemiluminescent nonradioactive kit (NEN Research
Products, Boston, Mass.).
|
PCR.
To determine whether aphA remained present
in recA (11), chromosomal DNAs from selected
strains were amplified with recA primers BA1916 and BA1917,
which flank the original aphA insertion site (Table 2). To
detect inversion of the C. fetus invertible region,
chromosomal DNAs from selected strains were amplified using primer
sapApromF2 (forward-facing promoter primer) with either
sapAR (reverse-facing sapA-specific primer) or
sapA2R (reverse-facing sapA2-specific primer)
(Table 2). To determine the frequency of inversion of the invertible
region, 10-fold (100 to 10
7) dilutions of
C. fetus chromosomal DNA were amplified with
sapAR and either sapApromF2 or sapFF
(forward-facing sapF primer). Primers from the
recA/eno region downstream of the aphA insertion
site were used in a parallel control PCR.
| |
RESULTS |
|---|
|
|
|---|
SLP expression of C. fetus cells.
We first sought
to confirm that the C. fetus strain (97-209) recovered from
the pregnant ewe was indeed expressing a different SLP than the
challenge strain, 97-211. Immunoblotting of this strain indicates the
expression of a 127-kDa SLP, not the 97-kDa SLP of wild-type strain 23D
or of strain 97-211, which was inoculated into the ewe (Fig.
1A). Although for 23D there was a minor
127-kDa band, for strains 97-209 and 97-211, only single SLP bands were present, consistent with their presumed recA phenotype
(11). The strains surviving incubation with MMS (97-211s and
97-209s; see below) showed the same SLP expression as the strains from which they were derived. To confirm that the SLPs were present on the
cell surface, the C. fetus cells were tested for serum resistance by incubation with NHS or with heat-inactivated NHS to
control for nonspecific killing. As expected, the control wild-type strain 23D was serum resistant (<1.0 log10 unit killing)
whereas S
strain 23B was highly sensitive (Fig. 1B).
Challenge strain 97-211 and the two strains recovered from the ewe all
were serum resistant, confirming SLP expression on their cell surface
(3).
|
Susceptibility of cells to MMS. Previous studies have shown that wild-type C. fetus cells survive treatment with the mutagenizing agent MMS, whereas recA strains are highly sensitive (11). Our studies confirmed that recA strain 97-211 was substantially more sensitive to MMS than was wild-type strain 23D (Fig. 1C). Strain 97-209, which changed to expression of a 127-kDa SLP (Fig. 1A) also was highly sensitive to MMS, consistent with a RecA phenotype. For both strains 97-211 and 97-209, several colonies survived a 60-min incubation with MMS. A representative colony from each (97-211s and 97-209s, respectively) was picked and reincubated with MMS to determine whether there had been selection for MMS resistance or whether their presence merely reflected the limits of the assay system. These MMS survivors were as susceptible to MMS as were their parental strains (Fig. 1C), indicating no selection for MMS resistance. These results indicate that during the ovine passage, there had been no change from the original RecA phenotype (11).
recA genotype of C. fetus strains.
To
assess the recA genotype of the ewe isolates, both Southern
hybridizations and PCR analyses were used. Southern hybridization using
both recA and aphA probes indicated that
aphA was stably integrated within recA in both
the strain used to challenge the ewes (97-211) and the strains
recovered (97-209 and 97-210), regardless of their SLP phenotype (Fig.
2). PCR using recA primers
B9088 and B9089 (Table 2) showed a 2.0-kb product in wild-type strain 23D and 3.4-kb products in strains 97-210, 97-209, and 97-211, confirming the presence of aphA within recA (data
not shown). In total, both the phenotypic and genotypic data indicate
that in strain 97-209, the change in SLP phenotype occurred in a
recA background.
|
Southern hybridization analyses provide evidence for
sap inversion in recA strain 97-209.
We
next sought to determine the mechanism for the change in SLP phenotype
in recA strain 97-209. To accomplish this, we performed a
series of Southern hybridizations using strain 97-209 and relevant controls to determine whether the changed phenotype could be explained by sap locus inversion. In Southern hybridizations of
PstI-digested chromosomal DNA, if inversion of the 6.2-kb
invertible region had occurred such that sapA2 now was
downstream of the unique sap promoter and able to express
the 127-kDa SLP, with use of a probe to the sapA 5'
conserved region, the loss of 4.8- and 5.7-kb hybridizing fragments and
the gain of 6.9- and 3.5-kb fragments would be expected. The C. fetus strains expressing a 97-kDa SLP (23D, 97-210, and 97-211)
showed the 5.7- and 4.8-kb bands, as expected, but these were absent in
97-209 and a new band at 3.5 kb was seen (data not shown). When an
NdeI digestion of chromosomal DNA was done and the same
sapA probe was used, a shift from a 1.2- to a 1.5-kb
hybridizing band was expected in strain 97-209 but not in the other
strains, and this was clearly observed (data not shown). Since use of
the sapA probe is associated with multiple bands,
hybridization of PstI-digested chromosomal DNA also was done
using a probe to sapF, which is present in a single copy within the invertible DNA fragment. Rearrangement permitting expression of the sapA2 product would be expected to produce a shift
from a 4.8- to a 3.5-kb sapF-hybridizing fragment (Fig.
3A), and this was observed for strain
97-209 but not for the control strains (Fig. 3B). Therefore, these
studies indicated that the change in SLP expression in strain 97-209 was due to inversion of the 6.2-kb invertible region, which placed
sapA2 downstream of the unique sap promoter.
|
PCR confirmation of inversion of the sap invertible region and estimation of its frequency. Since inversion of the 6.2-kb invertible region is believed to occur spontaneously in wild-type strains, we sought to test this phenomenon in strain 23D. Using primer sapApromF2, which is a forward-facing sapF primer in the region of the unique sap promoter, and reverse primers specific to either sapA or sapA2, we were able to obtain PCR products, indicating that routine culture of 23D resulted in a mixture of cells with the invertible region in either orientation (data not shown). Using these same primers for the recA strains 97-211 and 97-209 also showed that both products were present, confirming that populations of cells with the 6.2-kb invertible region in either orientation were present in both strains.
To estimate the frequency of inversion, these PCRs were repeated using serial dilutions of template DNA. A control PCR for a chromosomal locus (recA/eno), which does not rearrange, also was used (Fig. 4). For each strain studied, we could detect the recA/eno product in 10
6 dilutions
of the chromosomal DNA template. For wild-type strain 23D, the
frequency of inversion was approximately 10
1, comparing
the results of the two competing sapApromF2-based PCRs (Fig.
4). In contrast, for recA strains 97-211 and 97-209, the
frequencies were about 10
3 and 10
4
respectively, with the number of positive dilutions reflecting the
strain's phenotype (expression of a 97-kDa protein favors the reaction
with the sapAR primer, whereas expression of the 127-kDa
protein favors the reaction with the sapA2R primer) (Fig. 4). These results indicate that mutation of recA
substantially diminished but did not eliminate the sap
invertible-region inversion.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we confirmed that C. fetus strain 97-209, recovered from an experimentally infected ewe, expressed a 127-kDa SLP rather than the 97-kDa SLP expressed in the challenge strain (19). That strain 97-209 was serum resistant (4) is indicative of the surface localization of this protein (18). These results demonstrate that the shift in SLP expression that had occurred in vivo was not to produce a strain lacking SLP encapsulation (15, 16) but rather to an S+ variant expressing an alternative SLP.
Studies of susceptibility to MMS demonstrated that the variant strain 97-209 maintained the RecA phenotype, and both Southern hybridizations and PCR analyses showed that the original recA genotype of the challenge strain (97-211) remained in 97-209. Further, the few survivors of incubation with MMS showed a fully susceptible phenotype, which indicates that rather than selecting for MMS resistance, they represent the chance survivors at the limit of assay efficacy, rather than reversion to wild-type RecA function.
Given that RecA previously has been demonstrated to be necessary for
SLP switching, how then did C. fetus change its phenotype from expression of a 97-kDa SLP to expression of a 127-kDa SLP? Again,
both Southern hybridization and PCR analyses are consistent in
indicating that DNA inversion, involving the 6.2-kb invertible region had occurred in strain 97-209. DNA inversion involving the
sap invertible region is known to occur spontaneously, and in C. fetus mutant strain 23D:ACA2K101
(sapA::cat
sapA2::aphA) it was estimated to occur at a
frequency of 10
4 to 10
3 (9).
This rate of inversion recently has been confirmed in both PCR analyses
and studies of (phenotypic) shifts in antibiotic resistance for that
strain (Z.-C. Tu et al., unpublished data). For wild-type strain 23D,
our PCR dilution results indicate that the frequency of inversion is
about 10
1 (Fig. 4), which is approximately 100- to
1,000-fold greater than the previously published result
(11). Both results have been confirmed in multiple
experiments. One explanation for this 2- to 3-log10-unit
difference in inversion rate between wild-type strain 23D and mutant
strain 23D:ACA2K101 is that in the latter strain, antibiotic resistance
cassettes (cat and aphA in sapA and
sapA2, respectively) were inserted in the sapA 5'
conserved regions. Their presence at that location might interfere with the inversion process, especially since it substantially disrupts the
DNA homology that would be required for RecA-requiring recombination events. For E. coli, the frequency of homologous
recombination depends in part on the length of the homologous sequence
(7, 18, 22, 33, 34, 40). Thus, our present studies of strain 23D (Fig. 4) provide analysis of spontaneous in vitro inversion frequency in a strain with wild-type rather than mutated
sapA homologs.
Our results further indicate that sap inversion continues to
occur in the recA strains, but at a frequency also about 2 to 3 log10 units lower than for the wild-type strain (Fig.
4). Thus, while RecA function is critical for high-frequency
(10
1 to 10
2) inversion, there is a residual
recA-independent inversion mechanism that operates at lower
frequency. In other bacteria, recA-independent (site-specific) inversion is well recognized (14, 21). That at least two independent pathways can lead to inversion of the sap invertible region is an indication of the functional
significance of SLP antigenic variation for C. fetus. These
results suggest that the ability to change SLP expression is a critical
in vivo function for C. fetus (36). Thus, the
recovery of strain 97-209 during the course of experimental ovine
infection (19) could reflect strong in vivo selection for
the spontaneous variant.
The residual recA-independent inversion mechanism could reflect general (homologous) recombination using other pathways, analogous to the recBCD and recEF pathways of E. coli (14, 21, 37), for example. Alternatively, the inversion could reflect a site-specific mechanism involving a unique enzymatic activity. Studies to examine these possibilities are under way.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants R01 Al 24145 and R29-Al43548 from the National Institutes of Health, by the Medical Research Service of the Department of Veterans Affairs, and by the Wellcome Trust.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Medicine, New York University Medical Center, 550 First Ave., New York, NY 10016. Phone: (212) 263-6394. Fax: (212) 263-7700. E-mail: martin.blaser{at}med.nyu.edu.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Blaser, M. J. 1998. Campylobacter fetus:emerging infection and model system for bacterial pathogenesis at mucosal surfaces. Clin. Infect. Dis. 27:256-258[Medline]. |
| 2. |
Blaser, M. J., and E. C. Gotschlich.
1990.
Surface array protein of Campylobacter fetus:cloning and gene structure.
J. Biol. Chem.
265:14529-14535 |
| 3. | Blaser, M. J., and Z. Pei. 1993. Pathogenesis of Campylobacter fetus infections. Critical role of high molecular weight S-layer proteins in virulence. J. Infect. Dis. 167:372-377[Medline]. |
| 4. | Blaser, M. J., P. A. Smith, J. E. Repine, and K. A. Joiner. 1988. Pathogenesis of Campylobacter fetus infections. Failure to bind C3b explains serum and phagocytosis resistance. J. Clin. Invest. 81:1434-1444. |
| 5. | Blaser, M. J., P. F. Smith, and P. A. Kohler. 1985. Susceptibility of Campylobacter isolates to the bactericidal activity in human serum. J. Infect. Dis. 151:227-235[Medline]. |
| 6. |
Borst, P., and D. R. Greaves.
1987.
Programmed gene rearrangements altering gene expression.
Science
235:658-667 |
| 7. |
Deng, C., and M. R. Capecchi.
1992.
Reexamination of gene targeting frequency as a function of the extent of homology between the targeting vector and the target locus.
Mol. Cell. Biol.
12:3365-3371 |
| 8. | Dworkin, J., and M. J. Blaser. 1997. Molecular mechanisms of Campylobacter fetus surface layer protein expression. Mol. Microbiol. 26:433-440[CrossRef][Medline]. |
| 9. |
Dworkin, J., and M. J. Blaser.
1997.
Nested DNA inversion as a paradigm of programmed gene rearrangement.
Proc. Natl. Acad. Sci. USA
94:985-990 |
| 10. | Dworkin, J., and M. J. Blaser. 1996. Generation of Campylobacter fetus S-layer protein diversity utilizes a single promoter on an invertible DNA segment. Mol. Microbiol. 19:1241-1253[Medline]. |
| 11. |
Dworkin, J.,
O. L. Shedd, and M. J. Blaser.
1997.
Nested DNA inversion of Campylobacter fetus S-layer genes is recA dependent.
J. Bacteriol.
179:7523-7529 |
| 12. |
Dworkin, J.,
M. K. R. Tummuru, and M. J. Blaser.
1995.
The lipopolysaccharide-binding domain of the Campylobacter fetus S-layer protein resides within the conserved N terminus of a family of silent and divergent homologs.
J. Bacteriol.
177:1734-1741 |
| 13. |
Dworkin, J.,
M. K. R. Tummuru, and M. J. Blaser.
1995.
Segmental conservation of sapA sequences in type B Campylobacter fetus cells.
J. Biol. Chem.
270:15093-15101 |
| 14. | Dybvig, K. 1993. DNA rearrangements and phenotypic switching in prokaryotes. Mol. Microbiol. 10:465-471[CrossRef][Medline]. |
| 15. | Fogg, G. C., L. Yang, E. Wang, and M. J. Blaser. 1990. Surface-array proteins of Campylobacter fetus block lectin-mediated binding to type A lipopolysaccharide. Infect. Immun. 89:464-469. |
| 16. |
Fujimoto, S.,
A. Takade,
K. Amako, and M. J. Blaser.
1991.
Correlation between molecular size of surface-array protein and both morphology and antigenicity in the Campylobacter fetus S-layer.
Infect. Immun.
59:2017-2022 |
| 17. | Fujita, M., T. Moriya, S. Fujimoto, N. Hara, and K. Amako. 1997. A deletion in the sapA homologue cluster is responsible for the loss of the S-layer in Campylobacter fetus strain TK. Arch. Microbiol. 167:196-201[CrossRef][Medline]. |
| 18. |
Fujitani, Y., and I. Kobayashi.
1999.
Effect of DNA sequence divergence on homologous recombination as analyzed by a random-walk model.
Genetics
153:1973-1988 |
| 19. |
Grogono-Thomas, R.,
J. Dworkin,
M. J. Blaser, and D. G. Newell.
2000.
The role of the surface-layer proteins of Campylobacter fetus subspecies fetus in ovine abortion.
Infect. Immun.
68:1687-1691 |
| 20. | Hatfull, G. F., and N. D. F. Grindly. 1988. Resolvases and DNA-invertases: a family of enzymes active in site-specific recombination, p. 358-396. In R. Kucherlapati, and G. R. Smith (ed.), Genetic recombination. American Society for Microbiology, Washington, D.C. |
| 21. |
Henderson, I. R.,
P. Owen, and J. P. Nataro.
1999.
Molecular switches the ON and OFF of bacterial phase variation.
Mol. Microbiol.
33:919-932[CrossRef][Medline].
|
| 22. |
Jinks-Robertson, S.,
M. Michelitch, and S. Ramcharan.
1993.
Substrate length requirements for efficient mitotic recombination in Saccharomyces cerevisiae.
Mol. Cell. Biol.
13:3937-3950 |
| 23. | Johnson, R. C., M. F. Bruist, and M. I. Simon. 1986. Host protein requirements for in vitro site-specific DNA inversion. Cell 46:531-539[CrossRef][Medline]. |
| 24. | Kirillov, M., I. L. Shumakov, E. V. Nechaeva, L. N. Siniashina, and G. I. Karataev. 1993. Nucleotide sequence and properties of an inverted repeating element of a Bordetella pertussis chromosome. Genetika 29:1267-1277[Medline]. |
| 25. |
Labigne-Roussel, A.,
P. Courcoux, and L. Tompkins.
1988.
Gene disruption and replacement as a feasible approach for mutagenesis of Campylobacter jejuni.
J. Bacteriol.
170:1704-1708 |
| 26. | Mertens, G., A. Hoffman, H. Blocker, R. Frank, and R. Kahmann. 1984. Gin-mediated site-specific recombination in bacteriophage Mu DNA: overproduction and inversion in vitro. EMBO J. 3:2415-2421[Medline]. |
| 27. | Pei, Z., and M. J. Blaser. 1990. Pathogenesis of Campylobacter fetus infections. Role of surface array proteins in virulence in a mouse model. J. Clin. Invest. 85:1036-1043. |
| 28. |
Pei, Z.,
R. T. Ellison,
R. V. Lewis, and M. J. Blaser.
1988.
Purification and characterization of a family of high molecular weight surface-array proteins from Campylobacter fetus.
J. Biol. Chem.
263:6416-6420 |
| 29. | Robertson, B. D., and T. F. Meyer. 1992. Genetic variation in pathogenic bacteria. Trends Genet. 8:422-452[Medline]. |
| 30. | Roca, A. I., and M. M. Cox. 1990. The RecA protein: structure and function. Crit. Rev. Biochem. Mol. Biol. 25:415-430[Medline]. |
| 31. |
Sadowski, P.
1986.
Site-specific recombinases: changing partners and doing the twist.
J. Bacteriol.
165:341-347 |
| 32. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., p. 18.41-18.42. Cold Spring Harbor Laboratory Press, Plainview, N.Y. |
| 33. |
Shen, P., and H. V. Huang.
1986.
Homologous recombination in Escherichia coli: dependence on substrate length and homology.
Genetics
112:441-457 |
| 34. | Singer, B. S., L. Gold, P. Gauss, and D. H. Doherty. 1982. Determination of the amount of homology required for recombination in bacteriophage TG4. Cell 31:25-33[CrossRef][Medline]. |
| 35. |
Thompson, S. A.,
O. L. Shedd,
K. C. Ray,
M. H. Beins,
J. P. Jorgensen, and M. J. Blaser.
1998.
Campylobacter fetus surface layer proteins are transported by a type I secretion system.
J. Bacteriol.
180:6450-6458 |
| 36. | Thompson, S. A., and M. J. Blaser. 2000. Pathogenesis of Campylobacter fetus infections, p. 321-347. In I. Nachamkin, and M. J. Blaser (ed.), Campylobacter, 2nd ed. ASM Press, Washington, D.C. |
| 37. | van de Putte, P., and N. Goosen. 1992. DNA inversions in phages and bacteria. Trends Genet. 8:457-462[Medline]. |
| 38. |
Wang, E.,
M. M. Garcia,
M. S. Blake,
Z. Pei, and M. J. Blaser.
1993.
Shift in S-layer protein expression responsible for antigenic variation in Campylobacter fetus.
J. Bacteriol.
175:4979-4984 |
| 39. |
Wanner, B. L.,
M. R. Wilmes, and E. Hunter.
1988.
Molecular cloning of the wild-type phoM operon in Escherichia coli K-12.
J. Bacteriol.
170:279-288 |
| 40. |
Watt, V. M.,
C. J. Ingles,
M. S. Urdea, and W. J. Rutter.
1985.
Homology requirements for recombination in Escherichia coli.
Proc. Natl. Acad. Sci. USA
82:4768-4772 |
| 41. |
Yang, L.,
Z. Pei,
S. Fujimoto, and M. J. Blaser.
1992.
Reattachment of surface array proteins to Campylobacter fetus cells.
J. Bacteriol.
174:1258-1267 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|